Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects

By Gasser U.E.   Crevoisier C.   Ouwerkerk M.   Lankhaar G.   Dingemanse J.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 46, Iss. 2, 1998-09 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Cannabidiol enhances consolidation of explicit fear extinction in humans

By Das Ravi   Kamboj Sunjeev   Ramadas Mayurun   Yogan Kishoj   Gupta Vivek   Redman Emily   Curran H.   Morgan Celia  

Psychopharmacology, Vol. 226, Iss. 4, 2013-04 ,pp. : 781-792

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

By Vaz-da-Silva Manuel  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 435-446

Adis International

Access to resources Recommend Favorite

Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil

By Peretti Charles   Gierski Fabien   Harrois Sophie  

Psychopharmacology, Vol. 176, Iss. 2, 2004-11 ,pp. : 176-182

Springer Publishing Company

Access to resources Recommend Favorite

Results of the Cardiological Study Invest: A New Word in the Therapy of Patients with Hypertension

By Nikolaeva I.   Peters V.  

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 6, 2005-06 ,pp. : 339-340

Springer Publishing Company

Access to resources Recommend Favorite